<DOC>
	<DOCNO>NCT01051193</DOCNO>
	<brief_summary>This study design provide long term safety data TRI476 child inadequately-controlled partial seizure . This study conduct patient complete core study CTRI476B1301 . Blinding maintain transition dose adjustment phase extension study . All patient treat TRI476 dose adjustment phase onwards . The purpose study confirm TRI476 adjunctive therapy safe .</brief_summary>
	<brief_title>Long-term Safety Tolerability TRI476 ( Oxcarbazepine ) Children With Inadequately Controlled Partial Onset Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Oxcarbazepine</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>Patients complete doubleblind treatment phase core study ( B1301 ) . A parent/legal guardian must present give write consent patient enrol trial . Patients consent must obtain use assent document accord patient age . Females childbearing potential must negative pregnancy test Week 8 core study B1301 . Patients medical ineligibility enter extension , assess investigator site . Patients participate core study , complete ( prematurely discontinue ) Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Seizures</keyword>
	<keyword>oxcarbazepine</keyword>
	<keyword>child</keyword>
</DOC>